The Immunologic Character of Acquired Inhibitors of Antihemophilic Globulin (Factor VIII) and the Kinetics of Their Interaction with Factor VIII*
AUTOR(ES)
Shapiro, Sandor S.
RESUMO
Investigations were undertaken of the chemical nature and kinetics of interaction of three acquired inhibitors of Factor VIII. The inhibition was stoichiometric, one molecule of inhibitor (or one site on a molecule) being required to inactivate one molecule of Factor VIII. All three inhibitors were found to be monotypic antibodies of class IgG, Type K (γ2 κ2). This appears to be the second syndrome due to the production of monotypic antibody, and the first instance involving IgG immunoglobulins.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=297033Documentos Relacionados
- Detection of carriers of classic hemophilia using an immunologic assay for antihemophilic factor (factor VIII)
- Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's disease: With observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor
- Studies on the purification of antihemophilic factor (factor VIII): I. Precipitation Of Antihemophilic Factor By Concanavalin A
- Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII).
- Studies on the purification of antihemophilic factor (factor VIII): II. Separation of partially purified antihemophilic factor by gel filtration of plasma